# Choo Heng Tong

> Choo Heng Tong is a Series D investor at SG Growth Capital backing Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [SG Growth Capital](https://shizune.co/investors/profile/sg-growth-capital)
- Total investments: 1
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/heng-tong-choo-841b7232

Choo Heng Tong is a Series D investor at SG Growth Capital focused on Health Care and Biotechnology. Heng Tong holds dual appointments as Executive Vice President (Investments) at EDBI and Bio*One Capital, its dedicated biomedical sciences investment subsidiary. He is responsible for EDBI’s strategic growth capital for local companies as well as venture investments in biomedical sciences, and also oversee EDBI’s operations in the United States. Hehas over 15 years of experience in investments and industry development; including M&As, strategic planning, business development, and international growth into new markets, involving both multi-nationals and start-up organizations. He was previously with Singapore Economic Development Board where he worked with various industries such as biotechnology, pharmaceutical, and engineering companies to grow their business and operations in Asia. Currently, Heng Tong serves on the board of Maccine Pte Ltd, S*Bio Pte Ltd, QT Vascular Pte Ltd, Jurong Aromatics Corporation Pte Ltd and SPRING’s Growth Enterprise Fund Pte Ltd.

## Contacts

5 contacts available for Choo Heng Tong: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/choo-heng-tong?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| TriReme Medical | TriReme Medical, Inc. (TMI) is a privately held medical device company based in Pleasanton, California. Founded in 2005, it is dedicated to the development and manufacturing of novel stent technologies for the treatment of coronary artery disease (CAD) at or near bifurcations. | $17M | Series D |  |  |

1 of 1 investments shown.

## Co-investors
- [Three Arch Partners](https://shizune.co/investors/profile/three-arch-partners) — VC Fund, 1 deal together

## About SG Growth Capital

VC Fund · Singapore, Singapore

SG Growth Capital is an investment firm

2 contacts available at SG Growth Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Choo Heng Tong | Chief Executive Officer | — |
| Paul Ng | Chief Corporate Officer | https://shizune.co/investors/profile/paul-ng |

## Similar investors

### Similar stage
- [Sigma Partners](https://shizune.co/investors/profile/sigma-partners) — VC Fund
- [EDBI](https://shizune.co/investors/profile/edbi) — VC Fund
- [Trifecta Capital Advisors](https://shizune.co/investors/profile/trifecta-capital-advisors) — VC Fund

## FAQ

### What does Choo Heng Tong invest in?

Choo Heng Tong invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series D stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Choo Heng Tong?

Public channels for Choo Heng Tong include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co